🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Core Scientific secures Chief Legal Officer with new agreement

EditorIsmeta Mujdragic
Published 07/23/2024, 09:41 AM
CORZ
-

Core Scientific, Inc. (NASDAQ:CORZ), a company specializing in finance services and crypto asset management, has solidified its executive team with a new employment agreement for its Chief Legal and Administrative Officer, Todd M. DuChene. The agreement, effective as of Monday, ensures DuChene's continued role within the company and outlines his compensation and benefits.

Under the terms of the new agreement, DuChene will receive a base salary of $500,000. He is also eligible for participation in the annual incentive plan starting in 2024, with a target bonus equal to 100% of his base salary, based on the achievement of specific performance criteria. However, for the year 2024, his bonus will not be less than $500,000, regardless of whether the performance criteria are met.

Additionally, DuChene will partake in the Core Scientific, Inc. 2024 Stock Incentive Plan, receive standard executive benefits, and be reimbursed for certain business expenses by company policy. The company also plans to enter into an indemnification agreement with DuChene, mirroring those of its directors and other senior executives.

In terms of equity, DuChene was granted 1,003,633 time-based restricted stock units (RSUs) that vest over four years, with the first quarter vesting at the end of 2024. He also received an annual grant of 250,909 time-based RSUs and 83,637 performance-based RSUs, with vesting contingent upon service conditions and the achievement of performance goals.

Should DuChene's employment be terminated without cause or in connection with a change in control, he is entitled to severance benefits, including a continuation of his base salary for 12 months, payment of any unpaid bonuses, and acceleration of vesting for certain equity grants.

The article is based on an 8K filing.

In other recent news, Core Scientific Inc. received an Overweight rating from Cantor Fitzgerald, highlighting the company's strategic shift following its partnership with CoreWeave.

Analysts from Cantor Fitzgerald emphasized the transformational impact of this deal on the Bitcoin mining industry, particularly in terms of power consumption needs for AI. In parallel, H.C. Wainwright maintained a Buy rating on Core Scientific, reflecting confidence in the company's recent machine deal with Block-ePIC and its strategic partnerships.

Core Scientific has secured high-performance computing (HPC) hosting contracts totaling 270 megawatts, projected to generate over $4.7 billion in revenue over the next 12 years. The company also expanded its hosting agreement with CoreWeave, expecting to generate an additional $1.225 billion in cumulative revenue. Core Scientific's operational infrastructure has grown to 832 MW following a 72 MW expansion at its Denton, Texas data center.

The company's CEO, Adam Sullivan, has secured a new employment agreement that includes a base salary of $625,000 and an annual incentive target of 125% of the base salary, contingent upon performance criteria.

These are the recent developments in Core Scientific's operations and strategic initiatives.

InvestingPro Insights

As Core Scientific, Inc. (NASDAQ:CORZ) reinforces its executive team, investors and stakeholders may find additional context in the company's financial outlook and market performance, particularly when considering the compensation and incentives for its Chief Legal and Administrative Officer, Todd M. DuChene. According to InvestingPro data, Core Scientific boasts a high shareholder yield, which could be indicative of the company's commitment to returning value to its investors. Furthermore, analysts predict that the company will be profitable this year, aligning with the performance-based incentives outlined in DuChene's compensation package.

InvestingPro Tips suggest that Core Scientific has seen a strong return over the last month and the last three months, potentially reflecting a positive market response to the company's strategic initiatives and leadership decisions. While Core Scientific has not been profitable over the last twelve months, the anticipated net income growth this year could signal a turning point for the company's financial health.

For those looking to delve deeper into Core Scientific's performance and strategic direction, InvestingPro offers additional insights and tips. There are 8 more InvestingPro Tips available, providing a comprehensive analysis that investors can access to inform their decisions. To explore these insights, visit https://www.investing.com/pro/CORZ and remember to use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.